High levels of aluminum may alter biodistribution of technetium Tc 99m oxidronate, reducing skeletal uptake and increasing extraosseous uptake, potentially degrading imaging quality.
Source: NLP:technetium tc 99m oxidronate
Brand names: Technescan Hdp
Route: Intravenous
Contraindications
CONTRAINDICATIONS None known.
Pregnancy & Breastfeeding
Pregnancy Animal reproduction studies have not been conducted with technetium Tc 99m oxidronate. It is also not known whether technetium Tc 99m oxidronate can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. All radiopharmaceuticals, including Tehnescan HDP, have the potential to cause fetal harm depending on the fetal stage of development and the magnitude of the radiation dose. If considering Technescan HDP administration to a pregnant woman, inform the patient about the potential for adverse pregnancy outcomes based on the radiation dose from technetium Tc 99m oxidronate and the gestational timing of exposure.
3 interactions on record
High levels of aluminum may alter biodistribution of technetium Tc 99m oxidronate, reducing skeletal uptake and increasing extraosseous uptake, potentially degrading imaging quality.
Source: NLP:technetium tc 99m oxidronate
High levels of calcium may alter biodistribution of technetium Tc 99m oxidronate, reducing skeletal uptake and increasing extraosseous uptake, potentially degrading imaging quality.
Source: NLP:technetium tc 99m oxidronate
High levels of iron may alter biodistribution of technetium Tc 99m oxidronate, reducing skeletal uptake and increasing extraosseous uptake, potentially degrading imaging quality.
Source: NLP:technetium tc 99m oxidronate